Company news
Avita Medical, Inc. (NASDAQ:RCEL) news
Every Avita Medical, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
AVITA Medical Announces Participation at Canaccord Genuity Growth Conference
August 7, 2026
AVITA Medical to Announce Second Quarter 2026 Financial Results
July 14, 2026
AVITA Medical Reports First Quarter 2026 Financial Results
May 14, 2026
AVITA Medical Names Cary Vance as Chief Executive Officer
April 30, 2026
AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO
April 29, 2026
AVITA Medical to Announce First Quarter 2026 Financial Results
April 23, 2026
AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association
April 15, 2026
AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting
April 14, 2026
AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness
April 8, 2026
AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data
April 7, 2026
AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference
February 23, 2026
AVITA Medical to Host Investor Webinar Briefing
February 13, 2026
AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
January 25, 2026
AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
January 13, 2026
AVITA Medical Announces Changes to its Board of Directors
January 5, 2026
AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 18, 2025
AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference
November 24, 2025
AVITA® Medical Reports Third Quarter 2025 Financial Results
November 6, 2025
Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment
November 3, 2025
AVITA Medical to Announce Third Quarter 2025 Financial Results
October 29, 2025
AVITA Medical Welcomes Support for RECELL® in Burns in Australia
October 28, 2025
AVITA Medical Announces CEO Transition
October 16, 2025
CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds
October 1, 2025
AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across Europe
September 14, 2025
Real-World Data Shows Significant Reduction in Hospital Stay Using AVITA Medical’s RECELL® System
September 4, 2025
AVITA Medical Announces September Investor Conference Participation
August 21, 2025
AVITA Medical Successfully Completes Australian Equity Raise
August 12, 2025
AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation
August 7, 2025
AVITA Medical Announces Appointment of Michael Tarnoff, MD, FACS, to its Board of Directors and Transition of Board Chair Role to Cary Vance
August 6, 2025
AVITA Medical to Announce Second Quarter 2025 Financial Results
July 28, 2025
AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL
June 9, 2025
AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™
June 5, 2025
AVITA Medical’s RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards
June 3, 2025
AVITA Medical’s Acute Wound Care Showcase 2025 Streams Live Today
May 13, 2025
AVITA Medical Reports First Quarter 2025 Financial Results
May 8, 2025
AVITA Medical to Host Acute Wound Care Showcase on May 13, 2025
April 24, 2025
AVITA Medical to Announce First Quarter 2025 Financial Results
April 17, 2025
AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025
April 9, 2025
AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity
April 3, 2025
AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific
March 17, 2025
AVITA Medical to Present at TD Cowen’s 45ᵗʰ Annual Health Care Conference
February 26, 2025
AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results
February 13, 2025
AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance
January 7, 2025
AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds
December 23, 2024
AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market
December 19, 2024
AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 18, 2024
AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference
November 25, 2024
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
November 12, 2024
AVITA Medical Reports Third Quarter Financial Results
November 7, 2024